Cefuroxime is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Wg Critical Care, Llc. The primary component is Cefuroxime Sodium.
| Product ID | 44567-710_4d14b1a4-39d2-4e96-b84d-e193fbc99b16 |
| NDC | 44567-710 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cefuroxime |
| Generic Name | Cefuroxime |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2012-10-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA064125 |
| Labeler Name | WG Critical Care, LLC |
| Substance Name | CEFUROXIME SODIUM |
| Active Ingredient Strength | 750 mg/1 |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2012-10-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA064125 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-10-04 |
| Marketing End Date | 2012-08-01 |
| Marketing Category | ANDA |
| Application Number | ANDA064125 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-10-04 |
| Inactivation Date | 2019-11-27 |
| Ingredient | Strength |
|---|---|
| CEFUROXIME SODIUM | 750 mg/1 |
| SPL SET ID: | f4797359-d4a0-4967-86d3-d348518b3fe4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9567 | Cefuroxime | Cefuroxime |
| 0143-9568 | Cefuroxime | Cefuroxime |
| 0143-9569 | Cefuroxime | Cefuroxime |
| 0143-9976 | Cefuroxime | Cefuroxime |
| 0143-9977 | Cefuroxime | Cefuroxime |
| 0143-9979 | Cefuroxime | Cefuroxime |
| 44567-710 | Cefuroxime | Cefuroxime |
| 44567-711 | Cefuroxime | Cefuroxime |
| 44567-712 | Cefuroxime | Cefuroxime |
| 44567-720 | Cefuroxime | Cefuroxime |
| 44567-722 | Cefuroxime | Cefuroxime |